Fampridine SR is classified as a selective neuronal potassium channel blocker. Exactly how Fampridine SR improves mobility in multiple sclerosis (MS) patients is unknown. It has been proposed that Fampridine SR improves conduction in nerve fibers in which myelin has been damaged and that this improves mobility.
Fampridine SR is classified as a selective neuronal potassium
channel blocker. Exactly how Fampridine SR improves mobility in
multiple sclerosis (MS) patients is unknown. It has been proposed
that Fampridine SR improves conduction in nerve fibers in...
More
Multiple Sclerosis Foundation answered:Fampridine SR is classified as a selective neuronal potassium channel blocker. Exactly how Fampridine SR improves mobility in multiple sclerosis (MS) patients is unknown. It has been proposed that Fampridine SR improves conduction in nerve fibers in which myelin has been damaged and that this improves mobility.Fampridine SR is classified as a selective neuronal potassium channel blocker. Exactly how Fampridine SR improves mobility in multiple sclerosis (MS) patients is unknown. It has been proposed that Fampridine SR improves conduction in nerve fibers in... More
